GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 717 filers reported holding GLAXOSMITHKLINE PLC in Q2 2014. The put-call ratio across all filers is 0.74 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $231,000 | -21.2% | 5,698 | -18.0% | 0.06% | -32.6% |
| Q1 2017 | $293,000 | -6.7% | 6,951 | -4.7% | 0.09% | +270.8% |
| Q3 2016 | $314,000 | +5.7% | 7,290 | +13.3% | 0.02% | -81.1% |
| Q1 2015 | $297,000 | +8.0% | 6,432 | -0.1% | 0.13% | +5.8% |
| Q4 2014 | $275,000 | -15.4% | 6,441 | -8.8% | 0.12% | +3.4% |
| Q3 2014 | $325,000 | -3.3% | 7,064 | +12.3% | 0.12% | +10.5% |
| Q2 2014 | $336,000 | +3.7% | 6,288 | +3.8% | 0.10% | -5.4% |
| Q1 2014 | $324,000 | +55.0% | 6,055 | +55.0% | 0.11% | 0.0% |
| Q4 2013 | $209,000 | 0.0% | 3,906 | -6.0% | 0.11% | +8.8% |
| Q3 2013 | $209,000 | 0.0% | 4,157 | -0.4% | 0.10% | -3.8% |
| Q2 2013 | $209,000 | 0.0% | 4,173 | -6.1% | 0.11% | +2.9% |
| Q1 2013 | $209,000 | -8.3% | 4,446 | -15.1% | 0.10% | +7.3% |
| Q4 2012 | $228,000 | 0.0% | 5,237 | +6.4% | 0.10% | 0.0% |
| Q3 2012 | $228,000 | +0.9% | 4,923 | -0.6% | 0.10% | -8.6% |
| Q2 2012 | $226,000 | – | 4,953 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |